Navamedic ASA: Invitation to 2022 4th quarter presentation

Publisert: 13.02.2023

Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region

Publisert: 23.11.2022

Navamedic ASA: Q3 2022 financial results

Publisert: 01.11.2022

Navamedic ASA: Invitation to 2022 third quarter presentation

Publisert: 25.10.2022

Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation

Publisert: 20.10.2022

Navamedic ASA: Q2 and first half 2022 financial results

Publisert: 12.08.2022